Biotech

All Articles

Analysts explore Avidity's DMD succeed, revealing nuances in data

.Avidity Biosciences amazed financiers with stage 1/2 information in Duchenne muscle dystrophy (DMD)...

Actinogen's cortisol blocker fails period 2 depression research study

.Actinogen Medical's cortisol blocker has actually skipped the key endpoint of a period 2 research s...

Bivictrix makes a decision going exclusive only means to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of lots of a billion-dollar biob...

TPG tops up funds to $580M for expenditures all over life sciences

.Asset manager TPG, which has supported biotechs including Sionna Rehabs and Santa Clam Ana Biograph...

Merck stops period 3 TIGIT test in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT course has experienced one more drawback. Months after shuttering a phase 3 ...

After a difficult year, Exscientia folds up into Recursion

.After a year described through pipeline cuts, the departure of its chief executive officer and also...

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Therapy was impressed sufficient along with Harbour BioMed's bispecific invulnerable react...

A more detailed check out Ferocious Biotech's Fierce 15

.In this full week's episode of "The Leading Pipe," our company are actually diving in to Brutal Bio...

Lilly encounters phase 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party commemorating the commendation...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and...